Salidroside Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via AMPK-Dependent TXNIP/NLRP3 Pathway

Our previous studies suggested that salidroside could alleviate hepatic steatosis in type 2 diabetic C57BLKS/Lepr(db) (db/db) mice. The aim of the present study was to evaluate the therapeutic effect of salidroside on high-fat diet- (HFD-) induced nonalcoholic fatty liver disease (NAFLD) by investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Tao, Yang, Xiaoyan, Li, Wenjin, Wang, Qibin, Chen, Li, Wu, Dan, Bian, Fang, Xing, Shasha, Jin, Si
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081551/
https://www.ncbi.nlm.nih.gov/pubmed/30140371
http://dx.doi.org/10.1155/2018/8597897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081551/
https://www.ncbi.nlm.nih.gov/pubmed/30140371
http://dx.doi.org/10.1155/2018/8597897

Ejemplares similares